Internal Medicine · Great Neck, NY
NPI
1063468627
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
935 Northern Blvd Ste 105
Great Neck, NY, 11021
Phone (516) 487-0070
Groups this clinician bills Medicare through
Medicare paid, 2024
$436K
14,037 services
Medicare patients, 2024
181
Average age 75
Drug cost, 2024
$2.4M
9,019 prescriptions
Company payments, 2025
$4,296
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shahram D Shamekh was code 95004 (test - miscellaneous), 7,489 times for 103 patients. In total Shahram D Shamekh billed 14,037 services in 66 codes, and Medicare paid $436K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 7,489 | 103 | $3.58 | $27K |
| 96372 Injection Administration | Office | 542 | 129 | $12.90 | $6,989 |
| 94762 Pulmonary | Office | 442 | 143 | $23.71 | $10K |
| 87811 Immunoassay | Office | 428 | 141 | $40.55 | $17K |
| 99213 Office E&M - Established | Office | 325 | 119 | $78.06 | $25K |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 302 | 72 | $119.57 | $36K |
| J3411 Injection, thiamine hcl, 100 mg | Office | 236 | 124 | $1.74 | $412 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 236 | 124 | $1.05 | $247 |
| 99215 Office E&M - Established | Office | 218 | 118 | $161.20 | $35K |
| 99214 Office E&M - Established | Office | 201 | 115 | $111.93 | $22K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 196 | 41 | $0.09 | $17.93 |
| 99212 Office E&M - Established | Office | 185 | 99 | $45.37 | $8,394 |
| 96116 Behavioral Health Services | Office | 155 | 129 | $80.48 | $12K |
| 96132 Behavioral Health Services | Office | 147 | 123 | $112.62 | $17K |
| 94060 Pulmonary Function Testing | Office | 142 | 122 | $35.83 | $5,087 |
By year: 2022 $726K for 20,122 services; 2023 $680K for 20,765 services; 2024 $436K for 14,037 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87811 Immunoassay | 428 | 141 | $40.55 | $17K |
| 87804 Immunoassay | 73 | 34 | $16.22 | $1,184 |
| G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 64 | 64 | $45.42 | $2,907 |
| 87631 Infectious Agent Detection by DNA/RNA | 56 | 48 | $139.78 | $7,828 |
| 87880 Immunoassay | 37 | 34 | $16.20 | $599 |
Medicare prescription drug claims, 2024
In 2024, the drug Shahram D Shamekh prescribed most often to Medicare patients was Atorvastatin Calcium, with 405 prescriptions and refills. In total Shahram D Shamekh wrote 9,019 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 405 | 1,149 | 119 | $3,199 |
| Rosuvastatin Calcium Generic | 326 | 925 | 93 | $2,978 |
| Levothyroxine Sodium Generic | 297 | 745 | 72 | $3,963 |
| Metformin Hcl Generic | 275 | 781 | 83 | $3,366 |
| Omeprazole Generic | 262 | 664 | 81 | $3,061 |
| Amlodipine Besylate Generic | 245 | 711 | 80 | $1,397 |
| Losartan Potassium Generic | 231 | 653 | 70 | $1,901 |
| Ozempic Semaglutide | 222 | 250 | 38 | $216K |
| Metoprolol Succinate Generic | 210 | 562 | 57 | $3,143 |
| Farxiga Dapagliflozin Propanediol | 196 | 414 | 49 | $224K |
| Fluticasone Propionate Generic | 167 | 194 | 84 | $1,464 |
| Simvastatin Generic | 161 | 455 | 48 | $1,137 |
| Alendronate Sodium Generic | 155 | 191 | 35 | $592 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 155 | 202 | 43 | $5,720 |
| Diclofenac Sodium Generic | 155 | 175 | 31 | $80K |
Brand drugs: 2,246 claims; generic drugs: 6,741 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shahram D Shamekh $4,296 ($4,296 in general payments such as food, travel and fees) from 29 companies. The largest payer was Abbvie Inc. with $639.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 32 | $639 |
| AstraZeneca Pharmaceuticals LP AZN | 31 | $547 |
| Amgen Inc. AMGN | 13 | $545 |
| Novo Nordisk Inc NVO | 12 | $369 |
| Pfizer Inc. PFE | 20 | $300 |
| Lilly USA, LLC LLY | 11 | $275 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 12 | $204 |
| GlaxoSmithKline, LLC. GSK | 9 | $175 |
| Aimmune Therapeutics, Inc. | 7 | $166 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 6 | $139 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.